Non-Tuberculous Mycobacteria Drug Susceptibility Detection Kit (Culture Method)

Rapid antibody detection kit for Mycobacterium tuberculosis using colloidal gold immunochromatographic method. Designed for qualitative detection of TB-specific antibodies in human serum or plasma samples. Enables quick screening and diagnosis of tuberculosis infection in clinical and laboratory settings.

This kit is used for qualitative detection of Mycobacterium tuberculosis nucleic acid in sputum samples.

An in vitro diagnostic test kit for the detection of IgG antibodies against Mycobacterium tuberculosis using protein chip methodology. This is a class III in vitro diagnostic reagent product that has received regulatory approval. The kit is designed for tuberculosis serological diagnosis.

A colloidal gold-based detection kit for simultaneous screening of multiple drugs. This test kit provides rapid presumptive testing for various controlled substances.

A protein chip method-based detection kit for IgG antibodies against Mycobacterium tuberculosis. This kit is designed for serological testing of tuberculosis infection.

A diagnostic kit for the detection and identification of microorganisms using molecular techniques. The product supports infection diagnosis and microbial characterization in clinical laboratories.

Real-time PCR assay for differentiating Mycobacterium tuberculosis complex from non-tuberculous mycobacteria. Supports rapid TB diagnosis and identification of atypical mycobacterial infections.

Susceptibility testing products based on biomedical composite materials for antimicrobial resistance determination. These tests enable identification of pathogen resistance patterns to guide clinical treatment decisions.

MIKROLATEST MIC® antibiotic susceptibility testing kits determine bacterial resistance patterns to guide targeted antibiotic therapy. These in vitro diagnostic kits enable rapid identification of minimum inhibitory concentrations, supporting clinical decision-making in infectious disease management and infection control protocols.

dPCR assay for rapid and accurate detection of Mycobacterium tuberculosis and nontuberculous mycobacteria in clinical samples. Enables simultaneous identification of MTB and NTM species.

Mycoplasma identification and antimicrobial susceptibility testing kit for clinical microbiology laboratories. Enables rapid detection and characterization of Mycoplasma species with concurrent drug susceptibility profiling to guide targeted antimicrobial therapy. Designed for integration into automated microbiology workflows.